NantHealth, Inc. (NH)
| Market Cap | 271.00M |
| Revenue (ttm) | 71.16M |
| Net Income (ttm) | -94.80M |
| Shares Out | 111.32M |
| EPS (ttm) | -0.51 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 13 |
| Last Price | $2.21 |
| Previous Close | $2.38 |
| Change ($) | -0.17 |
| Change (%) | -7.14% |
| Day's Open | 2.36 |
| Day's Range | 2.18 - 2.43 |
| Day's Volume | 146,664 |
| 52-Week Range | 1.90 - 6.60 |
CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today reported financial ...
EL SEGUNDO, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced the launch of...
CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that it w...
EL SEGUNDO, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), today announced a new population health management product that pulls together disparate data to provide a full 360-degree picture of ...
CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help transform complex data into actionable insights, today reported financial results for...
NEW YORK & EL SEGUNDO, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced a ...
Investors need to pay close attention to NantHealth (NH) stock based on the movements in the options market lately.
EL SEGUNDO, Calif. & SAN ANTONIO, Texas--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today pr...
CULVER CITY, Calif. & EL SEGUNDO, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today a...
NantHealth, Inc. (NH) Q3 2020 Results - Earnings Call Transcript
CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, presented virtually with NantOmics and ImmunityBio on September 2...
CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced a series of secure Application Programming Interf...
CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, announced the national rollout of NaviNet AllPayer, a subscriptio...
NantHealth, Inc. (NH) Q2 2020 Results - Earnings Call Transcript
NantHealth, Inc. (NH) delivered earnings and revenue surprises of -16.67% and -3.38%, respectively, for the quarter ended June 2020.
NantHealth Acquires OpenNMS, the World’s Largest Open Source Network Management Application Platform
CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc.
NantHealth Points To The Future Of Healthcare
CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced the publication of a study in JCI Insight, a peer...
NantHealth (NH) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
NantHealth, Inc. (NH) Management on Q1 2020 Results - Earnings Call Transcript
NantHealth Inc (NH) delivered earnings and revenue surprises of 14.29% and -5.80%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
NantHealth, Inc. (NH) CEO Dr.
Shares of NantHealth Inc. soared 56% in premarket trading on Tuesday after the company said it had developed an artificial intelligence software used to improve lung-cancer diagnoses.
NantHealth Scores Milestone FDA Approval While SaaS Business Grows
NantHealth, Inc. (NH) CEO Patrick Soon Shiong on Q3 2019 Results - Earnings Call Transcript
NantHealth, Inc. (NH) delivered earnings and revenue surprises of -75.00% and -4.46%, respectively, for the quarter ended September 2019.
NantHealth, Inc. (NH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.
NantHealth's (NH) CEO Patrick Soon-Shiong on Q2 2019 Results - Earnings Call Transcript
NantHealth, Inc. (NH) delivered earnings and revenue surprises of 55.56% and 7.03%, respectively, for the quarter ended June 2019.
NantHealth, Inc. (NH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.
NantHealth, Inc. (NH) CEO Patrick Soon-Shiong on Q1 2019 Results - Earnings Call Transcript
NantHealth's (NH) CEO Patrick Soon-Shiong on Q4 2018 Results - Earnings Call Transcript
About NH
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States and internationally. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the... [Read more...]
| Industry Health Information Services | IPO Date Jun 2, 2016 |
| CEO Patrick Soon-Shiong | Employees 352 |
| Stock Exchange NASDAQ | Ticker Symbol NH |
Financial Performance
In 2020, NantHealth's revenue was $73.17 million, a decrease of -5.50% compared to the previous year's $77.43 million. Losses were -$56.33 million, -10.25% less than in 2019.
Analyst Forecasts
According to 2 analysts, the average rating for NantHealth stock is "Strong Buy." The 12-month stock price forecast is 3.75, which is an increase of 69.68% from the latest price.